Currently, although ischemia-modified albumin has been mainly used for diagnostic and prognostic purposes relating to acute coronary syndrome, elevated levels have also been linked to a poor outcome of patients experiencing acute chest pain and severe sepsis (37, 38). The gene discussed is ALB; the disease is acute coronary syndrome.